CytomX Therapeutics, Inc.
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

Abstract:

The invention relates generally to antibodies that bind CD166, activatable antibodies that specifically bind to CD166 and methods of making and using these anti-CD166 antibodies and anti-CD166 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.